MXCT vs TER
MaxCyte Inc (MXCT) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
MXCT currently screens at market cap $124.3M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the MXCT and TER stock pages for the full models.
Not investment advice.